Valuation: Shanghai MicroPort Endovascular MedTech Co., Ltd.

Market Cap 10.88B 1.61B 1.4B 1.3B 1.2B 2.27B 153B 2.31B 15.47B 6.08B 75.42B 6.03B 5.9B 259B P/E 2026 *
17.3x
P/E 2027 * 15.2x
Enterprise Value 7.85B 1.16B 1.01B 934M 862M 1.64B 110B 1.66B 11.15B 4.38B 54.36B 4.34B 4.25B 187B EV / Sales 2026 *
4.63x
EV / Sales 2027 * 4.78x
Free-Float
57.4%
Yield 2026 *
3.54%
Yield 2027 * 3.23%
Apr. 29 Microport Scientific says qtrly net profit attributable for Shanghai Microport Endovascular Medtech (Group) RMB154.8 mln RE
Apr. 29 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Mar. 30 Microport Scientific FY net profit attributable for Shanghai MicroPort Endovascular MedTech rmb563.3 million RE
Feb. 27 Microport Scientific logs FY net profit attributable for Shanghai MicroPort Endovascular MedTech RMB563.2 mln RE
Feb. 27 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
25-10-29 Microport Scientific updates on 9-month results of Shanghai Microport Endovascular Medtech RE
25-10-29 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-10-28 Tranche Update on Shanghai MicroPort Endovascular MedTech Co., Ltd.'s Equity Buyback Plan announced on October 29, 2024. CI
25-10-26 Shanghai MicroPort Endovascular MedTech Co., Ltd.'s Equity Buyback announced on October 29, 2024, has closed with 1,333,943 shares, representing 1.09% for CNY 140.1 million. CI
25-10-10 Tranche Update on Shanghai MicroPort Endovascular MedTech Co., Ltd.'s Equity Buyback Plan announced on October 29, 2024. CI
25-08-26 Microport Scientific says HY revenue of Shanghai MicroPort Endovascular MedTech RMB714.4 mln RE
25-08-26 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-15 MicroPort Scientific Flags H1 Profit, Revenue Decline in MicroPort Endovascular Medtech; Shares Fall 1% MT
1 day+0.49%
1 week-3.87%
Current month+1.61%
1 month-3.10%
3 months-12.10%
6 months-8.50%
Current year-1.73%
1 week 88.17
Extreme 88.17
92.46
1 month 83.33
Extreme 83.33
94.27
Current year 83.33
Extreme 83.33
116
1 year 83.33
Extreme 83.33
124.3
3 years 78.62
Extreme 78.62
141.14
5 years 78.62
Extreme 78.62
266.45
10 years 67.79
Extreme 67.7852
322.15
Manager TitleAgeSince
Chief Executive Officer 45 2021-07-14
Director of Finance/CFO 46 2021-10-27
Chief Tech/Sci/R&D Officer 49 2025-11-13
Director TitleAgeSince
Director/Board Member 49 2025-11-13
Director/Board Member 45 2021-09-09
Director/Board Member 40 2022-03-29
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%-3.87%-6.10%-23.90% 1.61B
+0.82%+0.99%-15.32%+10.65% 126B
+0.70%+1.15%+1.56%-3.18% 12.9B
-1.52%+2.95%+47.11%+112.20% 8.97B
+4.14%-2.38%-48.62%-71.98% 3.98B
-0.47%-1.34%+20.55%+45.56% 2.7B
+0.61%-7.70%-14.75%-24.08% 1.74B
+0.47%+10.24%-60.26%-83.72% 1.49B
+2.10%+14.44%-24.33%-60.71% 1.48B
Average +0.83%+1.55%-11.13%-11.02% 17.92B
Weighted average by Cap. +0.75%+1.04%-11.12%+11.49%

Financials

2026 *2027 *
Net sales 1.7B 250M 219M 202M 186M 354M 23.85B 360M 2.41B 947M 11.75B 939M 919M 40.4B 1.81B 268M 234M 216M 199M 378M 25.52B 385M 2.58B 1.01B 12.57B 1B 983M 43.23B
Net income 639M 94.25M 82.44M 76.04M 70.23M 133M 8.99B 135M 909M 357M 4.43B 354M 346M 15.22B 727M 107M 93.82M 86.53M 79.92M 152M 10.23B 154M 1.03B 406M 5.04B 403M 394M 17.32B
Net Debt -3.04B -448M -392M -362M -334M -634M -42.74B -644M -4.32B -1.7B -21.06B -1.68B -1.65B -72.39B -2.21B -325M -285M -262M -242M -460M -31.03B -468M -3.14B -1.23B -15.29B -1.22B -1.19B -52.55B
Logo Shanghai MicroPort Endovascular MedTech Co., Ltd.
Shanghai MicroPort Endovascular MedTech Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of interventional medical devices for the aorta and peripheral blood vessels. The Company's products are mainly categorized into aortic stents, peripheral vascular devices and others. The aortic stent products include thoracic aortic stent graft systems, abdominal aortic stent graft systems, and other surgical accessories. The peripheral vascular and other products mainly include intraoperative stent systems, peripheral arteries, peripheral veins, interventional oncology devices, and peripheral vascular surgical accessories. The Company conducts its businesses in domestic and overseas markets.
Employees
822
Date Price Change Volume
26-07-10 CN¥90.07 +0.49% 1,810,937
26-07-09 CN¥89.63 -0.21% 1,420,649
26-07-08 CN¥89.82 -1.01% 1,438,855
26-07-07 CN¥90.74 -2.17% 1,429,321
26-07-06 CN¥92.75 -1.01% 1,724,317
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
90.07CNY
Average target price
127.25CNY
Spread / Average Target
+41.28%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 688016 Stock